Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

G. Grignani, L. D'Ambrosio, Y. Pignochino, E. Palmerini, M. Zucchetti, P. Boccone, S. Aliberti, S. Stacchiotti, R. Bertulli, R. Piana, S. Miano, F. Tolomeo, G. Chiabotto, D. Sangiolo, A. Pisacane, A.P. Dei Tos, L. Novara, A. Bartolini, E. Marchesi, M. D'IncalciA. Bardelli, P. Picci, S. Ferrari, M. Aglietta

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)1360-1371
Number of pages12
JournalThe Lancet Oncology
Issue number10
Publication statusPublished - 2018

Cite this